Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Dragonfly Therapeutics Inc.
Sponsor

Dragonfly Therapeutics Inc.

United States 35 Gatehouse Drive, 02451-1215, United States

About the sponsor

Dragonfly Therapeutics Inc. is active in clinical research for advanced solid tumors, including unresectable, recurrent, and metastatic disease. Its studies focus on treatment-resistant cancers where new oncology approaches are needed.

  • Solid tumor oncology
  • Metastatic cancer
  • Recurrent malignancies

The sponsor’s portfolio includes investigational work in patients with advanced disease across selected indications, with attention to tumor control and clinical activity.

About Specializations

Dragonfly Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Df1001
  • Sponsor:Dragonfly Therapeutics Inc.

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Df6002
  • Sponsor:Dragonfly Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.